Osteoporosis
Conference Coverage
Vitamin D does not improve bone density, structure in healthy patients
ORLANDO – Daily use for 2 years did not affect areal BMD in the whole body, femoral neck, total hip, or spine, or...
Conference Coverage
Project ECHO helps osteoporosis specialists connect with PCPs
ORLANDO – Health care providers who participated in the ECHO program became more confident in 20 different domains...
Feature
Secondary prevention of osteoporotic fractures lacking
Osteoporotic fractures contribute significant health costs to the United States, yet secondary prevention efforts are lagging.
From the Journals
High-dose teriparatide tops standard dose in boosting BMD in postmenopausal women
A high dose of teriparatide in combination with denosumab increases bone mineral density (BMD) in postmenopausal women with osteoporosis to a...
From the Journals
Higher BMD linked to family history of diabetes in postmenopausal women
The connection may be related to insulin resistance.
From the Journals
Zoledronic acid reduces symptomatic periodontal disease in patients with osteoporosis
Coupled with good oral hygiene, the investigators suggest zoledronic acid might prevent development of osteonecrosis of the jaw.
From the Journals
Zoledronate maintains bone loss after denosumab discontinuation
The results suggest that, after achieving nonosteoporotic BMD with denosumab, a single intravenous infusion of zoledronate given 6 months after...
From the Journals
High-dose vitamin D for bone health may do more harm than good
A randomized trial showed an inverse dose-response relationship between high-dose vitamin D supplementation and bone quality in healthy adults.
From the Journals
FRAX with BMD may not be accurate for women with diabetes
Both major osteoporotic fracture and hip fracture are underestimated by FRAX with BMD in women with diabetes.
From the Journals
Self-reported falls can predict osteoporotic fracture risk
Over an almost 3-year period, about 3.5% of the population experience a major osteoporotic fracture.
From the Journals
Analysis finds no mortality reductions with osteoporosis drugs
A meta-analysis has found no evidence that osteoporosis drugs are associated with a reduction in mortality.